Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer
作者： Giandomenico Roviello , Andrea Ravelli , Karol Polom , Roberto Petrioli , Luigi Marano
DOI: 10.1016/J.CANLET.2016.01.014
关键词:
摘要: … particular regard to angiogenesis, apatinib is a novel receptor … gastric cancer patients, apatinib may be an interesting and … In this review, we summarize the available data of apatinib, …
core.ac.uk
units.it参考文章(44)
Giandomenico Roviello, Roberto Petrioli, Luigi Marano, Karol Polom, Daniele Marrelli, Armando Perrella, Franco Roviello, Angiogenesis inhibitors in gastric and gastroesophageal junction cancer Gastric Cancer. ,vol. 19, pp. 31- 41 ,(2016) , 10.1007/S10120-015-0537-5
Ramon Andrade de Mello, Andrea Marin Marques, António Araújo, None, HER2 therapies and gastric cancer: A step forward World Journal of Gastroenterology. ,vol. 19, pp. 6165- 6169 ,(2013) , 10.3748/WJG.V19.I37.6165
Domenico Ciliberto, Nicoletta Staropoli, Francesca Caglioti, Simona Gualtieri, Lucia Fiorillo, Silvia Chiellino, Antonina Maria De Angelis, Francesco Mendicino, Cirino Botta, Michele Caraglia, Pierfrancesco Tassone, Pierosandro Tagliaferri, A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? Cancer Biology & Therapy. ,vol. 16, pp. 1148- 1159 ,(2015) , 10.1080/15384047.2015.1056415
Luigi Marano, Rita Chiari, Alessio Fabozzi, Ferdinando De Vita, Virginia Boccardi, Giandomenico Roviello, Roberto Petrioli, Daniele Marrelli, Franco Roviello, Alberto Patriti, c-Met targeting in advanced gastric cancer: An open challenge Cancer Letters. ,vol. 365, pp. 30- 36 ,(2015) , 10.1016/J.CANLET.2015.05.028
Anna Dorothea Wagner, Nicholas LX Syn, Markus Moehler, Wilfried Grothe, Wei Peng Yong, Bee-Choo Tai, Jingshan Ho, Susanne Unverzagt, Chemotherapy for advanced gastric cancer Cochrane Database of Systematic Reviews. ,vol. 8, pp. 0- 0 ,(2017) , 10.1002/14651858.CD004064.PUB4
N Tanigawa, H Amaya, M Matsumura, T Shimomatsuya, Correlation between expression of vascular endothelial growth factor and tumor vascularity, and patient outcome in human gastric carcinoma. Journal of Clinical Oncology. ,vol. 15, pp. 826- 832 ,(1997) , 10.1200/JCO.1997.15.2.826
Roberto Petrioli, Edoardo Francini, Franco Roviello, Daniele Marrelli, Anna Ida Fiaschi, Letizia Laera, Giulia Rossi, V. Bianco, S. Brozzetti, Giandomenico Roviello, Sequential treatment with epirubicin, oxaliplatin and 5FU (EOF) followed by docetaxel, oxaliplatin and 5FU (DOF) in patients with advanced gastric or gastroesophageal cancer: a single-institution experience. Cancer Chemotherapy and Pharmacology. ,vol. 75, pp. 941- 947 ,(2015) , 10.1007/S00280-015-2715-X
Florian Lordick, William Allum, Fátima Carneiro, Emmanuel Mitry, Josep Tabernero, Patrick Tan, Eric Van Cutsem, Cornelis Van de Velde, Andrés Cervantes, None, Unmet needs and challenges in gastric cancer: the way forward. Cancer Treatment Reviews. ,vol. 40, pp. 692- 700 ,(2014) , 10.1016/J.CTRV.2014.03.002
S Rao, N Starling, D Cunningham, M Benson, A Wotherspoon, C Lüpfert, R Kurek, J Oates, J Baselga, A Hill, Phase I study of epirubicin, cisplatin and capecitabine plus matuzumab in previously untreated patients with advanced oesophagogastric cancer. British Journal of Cancer. ,vol. 99, pp. 868- 874 ,(2008) , 10.1038/SJ.BJC.6604622
Katherine Holmes, Owain Ll Roberts, Angharad M. Thomas, Michael J. Cross, Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition. Cellular Signalling. ,vol. 19, pp. 2003- 2012 ,(2007) , 10.1016/J.CELLSIG.2007.05.013